Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Osteoblasts are specialized, mononuclear cells responsible for the synthesis and mineralization of bone during both initial bone formation and later bone remodeling. They originate from mesenchymal stem cells and differentiate in the periosteum and endosteum. Their primary functions include synthesizing the organic components of bone matrix (primarily type I collagen), initiating mineralization by secreting enzymes like alkaline phosphatase, and regulating the local microenvironment by producing growth factors and hormones. After completing their role, osteoblasts can become osteocytes, undergo apoptosis, or become quiescent lining cells. Disruptions in osteoblast function can lead to diseases like osteoporosis and impaired fracture healing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Osteoblast.